Deltex Medical Group PLC

DEMG:JPJ / 0.02 GBX

Human health & social work services

Description

Deltex Medical uses proprietary haemodynamic monitoring technology to assist clinicians to improve outcomes for patients as well as increase throughput and capacity for hospitals. The Group's flagship, world-leading, ultrasound-based oesophageal doppler monitoring ("ODM") is supported by 24 randomised control trials conducted on anaesthetised patients. As a result, the primary application for ODM is focussed on guiding therapy for patients undergoing elective surgery as well as sedated patients in intensive care. The Group's new, TrueVue monitor makes the use of the ODM technology more intuitive and provides augmented data on the haemodynamic status of each patient.

Website

Linkedin

Company Details

Incorporated06/01/2000
Admission date21/02/2025
Securities in issue1,896,025,700
Market Cap£400k

Contact Details

E-Mailinfo@deltexmedical.com
Phone+44(0) 1243 774 837
AddressDeltex Medical, Terminus Road, Chichester, West Sussex, PO19 8TX

Company Snapshot

StatusLive
Price0.02 GBX
TradingContinuous
TickerDEMG:JPJ
ClassOrd
SettlementCREST
IndustryHuman health & social work services
CountryUnited Kingdom
Company Number03902895
ISINGB0059337583
CurrencyGBX

Downloads

Annual Report 2024 35425 KB
Annual Report 2023 1238 KB

Other Contacts

Equiniti (Registrar)

Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

0371 384 2030

Trade History

Date Quantity Mid Price Type Legend:
AT - Automatic Trade
AX - Agency Cross
PI - Primary Issuance
NT - Negotiated Trade
UT - Uncrossing Trade
05/08/2025 975,278 0.02
1

Management Information

Natalie Wettler

Chief Executive Officer

Nigel Keen

Chairman

Chris Jones

Board Member

TRANSACTING ON JP JENKINS

'Trading' on JP Jenkins is done via a matched bargain facility, this means that on instruction from your 'Broker' we will endeavour to match your shares against other buyer(s) or seller(s) who are also looking to transact. Requests to trade are performed on an availability basis, should an instruction be cancelled, altered or amended in anyway by an instruction from your broker then it shall lose its active place in the queue and reset to the end of list. JP Jenkins receives orders from brokers electronically via a FIX message or should your broker not have a FIX connection to our platform via telephone. If you do not have a UK registered stockbroker you will find a list of brokers that we have worked with to download here. You will also find a list of UK brokers at the bottom of this page and their contact details should you need to appoint one. JP Jenkins can ONLY take instruction to transact from a UK-registered stockbroker and cannot offer investment advice into companies displayed on our website. If you are unsure about trading please consult a financial advisor or wealth manager to assist you in determining what is right for you

  • 0207 469 0937

  • info@jpjenkins.com

  • 5th Floor

    101 Wigmore St

    London

    W1U 1QU

Copyright ©2025 JP Jenkins. All rights reserved. JP Jenkins is a trading name of Infinitx Limited a company incorporated in England & Wales with registered number 11551708 and whose registered office is at 101 Wigmore Street, 5th Floor, London, England, W1U 1QU (JPJ). JPJ (FRN 950991) is an appointed representative of Prosper Capital LLP (FRN453007) (Prosper) which is authorised and regulated by the Financial Conduct Authority. This website is a financial promotion by JPJ. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. JPJ acts for the companies listed on the website and provides services to authorised brokers but does not act for investors, consumers or any other person. The information on this website is obtained from the companies and other third parties and although JPJ considers these sources to be reliable, it makes no representation as to the accuracy of the information. Neither JPJ, Prosper nor any member of their group provides any advice on investing in unlisted shares generally or in the companies listed on the platform specifically, nor any legal, financial or tax advice of any kind. Nothing on this website and no communication from JPJ should be construed as an investment recommendation. If you have any doubt about the suitability of the investment, or you require financial advice, you should seek a personal recommendation from an appropriately qualified financial advisor. Investing in unlisted shares is high risk and should only be done as part of a diversified portfolio. Please read the RISK WARNINGS before making any investment decisions. Offers are only available through authorised persons. Any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. If you have any questions regarding these matters relating to information on this website you should consult a professional adviser.